Breaking Finance News

TheStreet upgraded Catalent Inc (NASDAQ:CTLT) to Hold in a report released today.

Showing a price of $24.70, Catalent Inc (NASDAQ:CTLT) traded 1.27% higher on the day. The last stock price is down 0.11% from the 200-day moving average, compared with the Standard & Poor’s 500 Index which has fallen -0.01% over the date range. The company has logged a 50-day moving average of $24.97 and two hundred day average of $25.62. Trade volume was was up over the average, with 2,827,846 shares of CTLT changing hands over the typical 1,233,420 shares.

TheStreet has upgraded Catalent Inc(NASDAQ:CTLT) to Hold in a statement released 8/17/2016.

Recent Performance Graph:

Catalent Inc (NASDAQ:CTLT)

A total of 6 equity analysts have issued a ratings update on Catalent Inc. Zero rate the company a strong buy, 0 rate the stock a buy, 0 analysts rate the company a hold, 0 rate the company to underperform, and finally 0 analystsrate the company as sell with a consensus target of $27.92

With a market capitalization of $0.0, Catalent Inc has a 52 week low of $18.92 and a one-year high of $32.24 with a P/E ratio of 29.

Brief Synopsis On Catalent Inc (NASDAQ:CTLT)

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and and global comparator sourcing services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *